Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D | P28221 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.36 |
| ▸ | RORA | P35398 | 1/20 | 0.36 |
| ▸ | RORC | P51449 | 1/20 | 0.36 |
| ▸ | RORB | Q92753 | 1/20 | 0.36 |
| ▸ | KIF11 | P52732 | 2/20 | 0.36 |
| ▸ | DNMT1 | P26358 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20857914 | 0.93 | HTR1D (0.40) | HTR1DPGRRORARORCRORB | |
| SCHEMBL20857990 | 0.91 | HTR1D (0.39) | HTR1DPGRRORARORCRORB | |
| SCHEMBL20857868 | 0.90 | KIF11 (0.40) | HTR1DPGRRORARORCRORB | |
| SCHEMBL25665364 | 0.86 | KIF11 (0.44) | HTR1DPGRRORARORCRORB | |
| SCHEMBL22679269 | 0.84 | KIF11 (0.38) | HTR1DPGRRORARORCRORB | |
| SCHEMBL20857841 | 0.84 | KIF11 (0.40) | HTR1DPGRRORARORCRORB | |
| SCHEMBL26261704 | 0.84 | PGR (0.36) | HTR1DPGRRORARORCRORB | |
| SCHEMBL20857858 | 0.83 | HTR1D (0.41) | HTR1DPGRRORARORCRORB | |
| SCHEMBL21579246 | 0.83 | HTR1D (0.36) | HTR1DPGRRORARORCRORB | |
| SCHEMBL20857862 | 0.82 | KIF11 (0.41) | HTR1DPGRRORARORCRORB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11569449-B2 | Organic electroluminescence device and novel compound | IDEMITSU KOSAN CO., LTD. (JP) | 2023-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11569449-B2 | Organic electroluminescence device and novel compound | PIEZO1, TMEM109, OXA1L | HTR1D 1918/4885PGR 2808/4885RORA 2765/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.